gptkbp:instanceOf
|
hormone
|
gptkbp:administeredBy
|
gptkb:Injection
|
gptkbp:affectsOrgan
|
gptkb:Adipose_tissue
Liver
|
gptkbp:aminoAcidCount
|
29
|
gptkbp:CASNumber
|
16941-32-5
|
gptkbp:category
|
Glucagon receptor agonists
Pancreatic hormones
Peptide hormones
|
gptkbp:discoveredBy
|
gptkb:C.P._Kimball
gptkb:John_R._Murlin
|
gptkbp:discoveredIn
|
1923
|
gptkbp:encodedBy
|
gptkb:GCG_gene
|
gptkbp:enemyOf
|
gptkb:Insulin
|
gptkbp:halfLife
|
3–6 minutes
|
gptkbp:hasMolecularFormula
|
C153H225N43O49S
|
https://www.w3.org/2000/01/rdf-schema#label
|
Glucagon
|
gptkbp:improves
|
Blood glucose level
|
gptkbp:inhibitedBy
|
gptkb:Insulin
gptkb:Glycogenesis
gptkb:Somatostatin
High blood glucose
|
gptkbp:MeSH_ID
|
D005951
|
gptkbp:predecessor
|
gptkb:Proglucagon
|
gptkbp:producedBy
|
Alpha cells of pancreas
|
gptkbp:promotion
|
gptkb:Gluconeogenesis
gptkb:Glycogenolysis
Epinephrine
Low blood glucose
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1201209
16132397
DB00013
|
gptkbp:recipient
|
gptkb:Glucagon_receptor
|
gptkbp:structureType
|
Peptide hormone
|
gptkbp:UNII
|
7J22XCU6G8
|
gptkbp:usedFor
|
Severe hypoglycemia
|
gptkbp:bfsParent
|
gptkb:Antidotes
|
gptkbp:bfsLayer
|
5
|